|
| Issue Date | Title | Author(s) |
| 2022 | Hands-on synthetic approaches and biological activities of anthranilic acid derivatives: A mini-review | Nasr, Tamer; Aboshanab, Ahmed; Abouzid, Khaled ; Zaghary, Wafaa |
| 25-Oct-1996 | Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand | Khanolkar, A D; Abadji, V; Lin, S; Hill, W A; Taha, G; Abouzid, Khaled ; Meng, Z; Fan, P; Makriyannis, A |
| 15-Dec-2017 | How to train your inhibitor: Design strategies to overcome resistance to Epidermal Growth Factor Receptor inhibitors | Milik, Sandra N; Lasheen, Deena S; Serya, Rabah ; Abouzid, Khaled A M; Khaled A M Abouzid |
| 13-Nov-2018 | Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axis | Ge, Xin; Pan, Min-Hong; Wang, Lin; Li, Wei; Jiang, Chengfei; He, Jun; Abouzid, Khaled ; Liu, Ling-Zhi; Shi, Zhumei; Jiang, Bing-Hua |
| Mar-2022 | Identification of a promising hit from a new series of pyrazolo[1,5-a]pyrimidine based compounds as a potential anticancer agent with potent CDK1 inhibitory and pro-apoptotic properties through a multistep in vitro assessment | Elgiushy, Hossam R; Mohamed, Sameh H; Sawaf, Hussein; Hassan, Zeinab; Abou-Taleb, Nageh A; El-Labbad, Eman M; Hassan, Ashraf S; Abouzid, Khaled A M; Abouzid, Khaled ; Ali Taha, Heba |
| Dec-2018 | Identification of new pyrrolo[2,3-d]pyrimidines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, biological evaluation and molecular modeling | Adel, Mai; Serya, Rabah ; Lasheen, Deena S. ; Khaled A M Abouzid |
| 8-Mar-2022 | Identification of novel furo[2,3-d]pyrimidine based chalcones as potent anti-breast cancer agents: synthesis, in vitro and in vivo biological evaluation | Mansour, Mai A; Oraby, Mamdouh A; Muhammad, Zeinab A; Lasheen, Deena ; Gaber, Hatem M; Khaled A M Abouzid |
| 2019 | Identification of novel pyrazole and benzimidazole based derivatives as PBP2a inhibitors: Design, synthesis, and biological evaluation | Shalaby, Menna-Allah; Dokla, Eman ; Serya, Rabah ; Abouzid, Khaled |
| Jul-2013 | In silico design: extended molecular dynamic simulations of a new series of dually acting inhibitors against EGFR and HER2 | Ahmed, Marawan; Sadek, Maiada M; Abouzid, Khaled ; Wang, Feng |
| 1-Dec-2021 | Indolin-2-one derivatives as selective Aurora B kinase inhibitors targeting breast cancer | Dokla, Eman ; Abdel-Aziz, Amal Kamal; Milik, Sandra N.; Mahmoud, Amr H.; Saadeldin, Mona Kamal; McPhillie, Martin J.; Minucci, Saverio; Khaled A M Abouzid |
| 2022 | Insights into the design of inhibitors of the EGFR family with anticancer activity overcoming resistance: A case of optimizing thieno[2,3-d]pyrimidine-based EGFR inhibitors | Milik, SN; Abdel-Aziz, AK; El-Hendawy, MM; El-Gogary, RI; Saadeldin, MK; Minucci, S; Klein, CD; Abouzid, Khaled |
| 1-Apr-2012 | Integrated structure-based activity prediction model of benzothiadiazines on various genotypes of HCV NS5b polymerase (1a, 1b and 4) and its application in the discovery of new derivatives | Ismail, Mohamed A H; Abou El Ella, Dalal ; Khaled A M Abouzid ; Mahmoud, Amr H |
| 1-Sep-2020 | An investigative study of antitumor properties of a novel thiazolo[4,5-d]pyrimidine small molecule revealing superior antitumor activity with CDK1 selectivity and potent pro-apoptotic properties | Mohamed, Sameh H; Elgiushy, Hossam R; Hammad, Sherif F; Abou-Taleb, Nageh A; A M Abouzid, Khaled; Abouzid, Khaled ; Hassan, Zeinab; Ali Taha, Heba |
| 1-Sep-2011 | Labeling and Biological Evaluation of 99mTc-Cefotaxime for infective Inflammation Diagnosis | M. A. Motaleb; A. A. El Mohty; M. A. El Garhy; Mohamed abdel Hamid Ismail; Abouzid, Khaled ; Tamer M. Sakr |
| 15-Feb-2006 | Ligand design and synthesis of new imidazo[5,1-b]quinazoline derivatives as alpha1-adrenoceptor agonists and antagonists | Ismail, Mohamed A H; Aboul-Enein, Mohamed N Y; Abouzid, Khaled ; Serya, Rabah A T |
| 1-Dec-2013 | Ligand design, synthesis and biological anti-HCV evaluations for genotypes 1b and 4a of certain 4-(3- & 4-[3-(3,5-dibromo-4-hydroxyphenyl)-propylamino] phenyl) butyric acids and 3-(3,5-dibromo-4-hydroxyphenyl)-propylamino- acetamidobenzoic acid esters | Ismail, Mohamed Abdel Hamid; Mohamed, Nasser Saad; Dokla, Eman ; Khaled A M Abouzid |
| 2021 | Lipid polymer hybrid nanocarriers as a combinatory platform for different anti-SARS-CoV-2 drugs supported by computational studies | Abdel-Bar, Hend Mohamed; Abdallah, Inas A.; Fayed, Marwa A. A.; Moatasim, Yassmin; Mostafa, Ahmed; El-Behairy, Mohammed Farrag; Elimam, Hanan; Elshaier, Yaseen A. M. M.; Abouzid, Khaled |
| 2009 | Lonazolac analogues: molecular modeling, synthesis, and in vivo anti-inflammatory activity | Ismail, MAH; Lehmann, J; Abou El Ella, D.A. ; Albohy, A; Abouzid, Khaled |
| Nov-2017 | Medicinal Attributes of Thienopyrimidine Based Scaffold Targeting Tyrosine Kinases and Their Potential Anticancer Activities | Ghith, Amna; Ismail, Nasser S M; Youssef, Khairia; Abouzid, Khaled |
| 2021 | Medicinal Chemistry Strategies Towards SO2 Donors as Research Tools and Potential Therapeutics | El-Labbad, Eman M; Ji, Xingyue; Abouzid, Khaled ; Wang, Binghe |
